The feasibility and accuracy of evaluating lipid management performance metrics using an electronic health record.
暂无分享,去创建一个
[1] Jason Wang,et al. Validity of electronic health record-derived quality measurement for performance monitoring , 2012, J. Am. Medical Informatics Assoc..
[2] W. Shrank,et al. Adherence to statin therapy in elderly patients after hospitalization for coronary revascularization. , 2011, The American journal of cardiology.
[3] Steve Evans,et al. The DEDUCE Guided Query tool: Providing simplified access to clinical data for research and quality improvement , 2011, J. Biomed. Informatics.
[4] Elizabeth DeLong,et al. ACCF/AHA/ACR/SCAI/SIR/SVM/SVN/SVS 2010 performance measures for adults with peripheral artery disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures, the American College of Radiology, the Society for Cardiac Angiography and I , 2010, Journal of the American College of Cardiology.
[5] R. Bonow,et al. ACCF/AHA/ACR/SCAI/SIR/SVM/SVN/SVS 2010 performance measures for adults with peripheral artery disease. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures, the American College of Radiology, the Society for Cardiac Angiography and I , 2010, Journal of vascular surgery.
[6] D. Blumenthal,et al. The "meaningful use" regulation for electronic health records. , 2010, The New England journal of medicine.
[7] E. Benjamin,et al. AHA/ACCF [corrected] 2009 performance measures for primary prevention of cardiovascular disease in adults: a report of the American College of Cardiology Foundation/American Heart Association task force on performance measures (writing committee to develop performance measures for primary prevention , 2009, Circulation.
[8] N. Unwin,et al. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National , 2009 .
[9] Lawrence A Leiter,et al. Discordance between physicians' estimation of patient cardiovascular risk and use of evidence-based medical therapy. , 2008, The American journal of cardiology.
[10] R. Califf,et al. Long-term clinical outcomes following coronary stenting. , 2008, Archives of internal medicine.
[11] H. Krumholz,et al. ACC/AHA 2008 performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to develop performance measures for ST-elevation and non-ST-eleva , 2008, Circulation.
[12] K. Eagle,et al. Atherosclerosis Secondary Prevention Performance Measures After Coronary Bypass Graft Surgery Compared With Percutaneous Catheter Intervention and Nonintervention Patients in the Get With the Guidelines Database , 2007, Circulation.
[13] J. Ornato,et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patie , 2007, Journal of the American College of Cardiology.
[14] Stephen D. Persell,et al. Automated Review of Electronic Health Records to Assess Quality of Care for Outpatients with Heart Failure , 2007, Annals of Internal Medicine.
[15] Stephen D. Persell,et al. Assessing the validity of national quality measures for coronary artery disease using an electronic health record. , 2006, Archives of internal medicine.
[16] M. Pfeffer,et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute. , 2006, Journal of the American College of Cardiology.
[17] M. Pfeffer,et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. , 2006, Circulation.
[18] P. Box. Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease , 2006 .
[19] Jun Ma,et al. National Trends in Statin Use by Coronary Heart Disease Risk Category , 2005, PLoS medicine.
[20] J. Ornato,et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). , 2004, Circulation.
[21] S. Grundy,et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[22] F. Billari,et al. does it matter? , 2007 .
[23] Timothy J Gardner,et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). , 2004, Circulation.
[24] Sankey V. Williams,et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). , 2003, Circulation.
[25] J. Mckenney,et al. National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) , 2002 .
[26] E. DeLong,et al. Discordance of Databases Designed for Claims Payment versus Clinical Information Systems: Implications for Outcomes Research , 1993, Annals of Internal Medicine.
[27] J. Jollis,et al. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. , 1993, Journal of clinical epidemiology.
[28] E L Hannan,et al. Clinical Versus Administrative Data Bases for CABG Surgery: Does it Matter , 1992, Medical care.
[29] F. Harrell,et al. The evolution of medical and surgical therapy for coronary artery disease. A 15-year perspective. , 1989, JAMA.